Tuning Macrophage Phenotype to Mitigate Skeletal Muscle Fibrosis

J Immunol. 2020 Apr 15;204(8):2203-2215. doi: 10.4049/jimmunol.1900814. Epub 2020 Mar 11.

Abstract

Myeloid cells are critical to the development of fibrosis following muscle injury; however, the mechanism of their role in fibrosis formation remains unclear. In this study, we demonstrate that myeloid cell-derived TGF-β1 signaling is increased in a profibrotic ischemia reperfusion and cardiotoxin muscle injury model. We found that myeloid-specific deletion of Tgfb1 abrogates the fibrotic response in this injury model and reduces fibro/adipogenic progenitor cell proliferation while simultaneously enhancing muscle regeneration, which is abrogated by adaptive transfer of normal macrophages. Similarly, a murine TGFBRII-Fc ligand trap administered after injury significantly reduced muscle fibrosis and improved muscle regeneration. This study ultimately demonstrates that infiltrating myeloid cell TGF-β1 is responsible for the development of traumatic muscle fibrosis, and its blockade offers a promising therapeutic target for preventing muscle fibrosis after ischemic injury.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Cardiotoxins
  • Fibrosis / complications
  • Fibrosis / immunology*
  • Fibrosis / pathology*
  • Macrophages / immunology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Muscle, Skeletal / immunology*
  • Muscle, Skeletal / pathology*
  • Myeloid Cells / immunology*
  • Myeloid Cells / pathology
  • Phenotype
  • Reperfusion Injury / chemically induced
  • Reperfusion Injury / complications
  • Reperfusion Injury / immunology
  • Transforming Growth Factor beta1 / immunology*

Substances

  • Cardiotoxins
  • Tgfb1 protein, mouse
  • Transforming Growth Factor beta1